All Kallikrein 13 reagents are produced in house and quality controlled, including 6 Kallikrein 13 Antibody, 2 Kallikrein 13 ELISA, 26 Kallikrein 13 Gene, 1 Kallikrein 13 Lysate, 1 Kallikrein 13 Protein, 3 Kallikrein 13 qPCR. All Kallikrein 13 reagents are ready to use.
Recombinant Kallikrein 13 proteins are expressed by HEK293 Cells with fusion tags as C-cleavage, C-His.
Kallikrein 13antibodies are validated with different applications, which are ELISA, ELISA(Cap), WB.
Kallikrein 13cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each Kallikrein 13 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.
Kallikrein 13ELISA Kit are quality controlled by 8 internation QC standard which guarantee every ELISA Kit with high quality.
Tissue kallikrein 13 (hK13), also known as KLK-L4 (kallikrein-like gene 4), is a member of the human tissue kallikrein family of serine proteases having diverse physiological functions in many tissues. The KLK13 gene resides on chromosome 19q13.3-4 along with other 14 members in a gene cluster and shares a high degree of homology. KLK13 is a trypsin-like, secreted serine protease expressed specifically in the testicular tissue including prostate, salivary gland, breast, and testis. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and may play a role in metastasis. KLK13 may be involved in the pathogenesis and/or progression of breast and ovary cancers, and is regarded as a novel cancer biomarker. In addition, KLK13 interacts and forms complexes with several serum protease inhibitors, such as alpha2-macroglobulin, and its expression is regulated by steroid hormones.